Enterovirus 71 (EV71) is a common cause of hand, foot and mouth disease-a disease endemic especially in the Asia-Pacific region 1 . Scavenger receptor class B member 2 (SCARB2) is the major receptor of EV71, as well as several other enteroviruses responsible for hand, foot and mouth disease, and plays a key role in cell entry 2 . The isolated structures of EV71 and SCARB2 are known [3] [4] [5] [6] , but how they interact to initiate infection is not. Here, we report the EV71-SCARB2 complex structure determined at 3.4 Å resolution using cryoelectron microscopy. This reveals that SCARB2 binds EV71 on the southern rim of the canyon, rather than across the canyon, as predicted 3, 7, 8 . Helices 152-163 (α5) and 183-193 (α7) of SCARB2 and the viral protein 1 (VP1) GH and VP2 EF loops of EV71 dominate the interaction, suggesting an allosteric mechanism by which receptor binding might facilitate the low-pH uncoating of the virus in the endosome/lysosome. Remarkably, many residues within the binding footprint are not conserved across SCARB2-dependent enteroviruses; however, a conserved proline and glycine seem to be key residues. Thus, although the virus maintains antigenic variability even within the receptor-binding footprint, the identification of binding 'hot spots' may facilitate the design of receptor mimic therapeutics less likely to quickly generate resistance.
, with around two million cases every year since 2010. While coxsackievirus A16 (CV-A16) and EV71 are major aetiological agents of HFMD, a variety of viruses in the genus Enterovirus, including many other type A and some type B enteroviruses, also cause the disease 1 . HFMD usually leads to relatively mild symptoms, such as fever, oral ulcerations and swellings on the hands and feet. However, EV71 infection is sometimes associated with cardiac and central nervous system complications and even death 1 . Enteroviruses belong to the picornavirus family of icosahedral, unenveloped viruses 10 . They contain a positive-sense single-stranded RNA genome, which on release into the cytoplasm is directly translated by host ribosomes, initiating infection. Initial stages of infection involve attachment to a host cell receptor, internalization, uncoating (which for enteroviruses is presumed to occur via expansion of the particle following ejection of a lipid pocket factor from the VP1 β -barrel resulting in a cascade of structural rearrangements 11 ) and release of the genome through a membrane pore into the cytoplasm 12 . Correct engagement with a specific receptor is critical to infectivity and can control virus tropism at both the species and tissue level 13 . This makes receptor-virus interactions attractive targets for antiviral therapeutics, since it may be more difficult for a virus to acquire resistance to such a compound than to a classic enzyme inhibitor. Recently, a number of receptors have been identified for many of the aetiological agents of HFMD. Notable receptors include scavenger receptor class B member 2 (SCARB2; a receptor for EV71, CV-A16 and a subgroup of type A enteroviruses) 2, 14 , kringle-containing transmembrane protein 1 (KREMEN1) for another group of type A enteroviruses including CV-A10 (ref. 15 ), P-selectin glycoprotein ligand-1 for EV71, and coxsackievirus and adenovirus receptor (CAR) and decay-accelerating factor (DAF) for group B enteroviruses 16 . Receptor usage correlates with the capsid structure, indicating that receptor switching drives evolution (Fig. 1a) . In the absence of high-resolution structures for receptor-EV71 complexes, it has been inferred that SCARB2 binds across the socalled canyon-a depression that in enteroviruses encircles the icosahedral fivefold axes and harbours the binding sites for slender immunoglobulin-domain-based receptors 17 , although SCARB2 is a much bulkier molecule.
SCARB2, also known as lysosomal integral membrane protein-2, is a type III membrane protein with amino (N)-and carboxy (C)-terminal transmembrane helices 18 . It is found especially in lysosomal limiting membranes and its 400-residue luminal domain is heavily glycosylated with nine potential N-linked glycosylation sites 6 . SCARB2 has a major role in endo/lysosomal membrane organization, with mutations causing several neurodegenerative and renal diseases. There is good evidence that SCARB2 attachment mediates EV71 internalization and uncoating 19, 20 . However, it has been established that uncoating requires not only attachment to SCARB2, but also low pH 3 . This implies that binding to SCARB2 might destabilize the virus particle at low pH (leading to the formation of expanded or ' A-particles' 5, 11 ). Our aim was to visualize the initial attachment complex, so we used a variant of EV71 genotype B2 whose infectivity is enhanced at low pH by a single mutation in VP1 (N104S; see Methods). The particles were further stabilized by replacing the natural pocket factor with a potent expansion inhibitor, NLD (see Methods). We determined the structure of the luminal domain of SCARB2 in complex with this stabilized form of EV71 at a pH of 5.1 by cryo-electron microscopy (cryo-EM; see Methods and Supplementary Fig. 1a ). We found that SCARB2 binds to the 'southern rim' of the canyon, interacting with loops from two of the major capsid proteins, VP2 and VP1 (Fig. 1b) . The structure (Fig. 1c,d , Methods and Supplementary Table 1 ). The viron is unexpanded, with NLD remaining bound in the VP1 pocket ( Fig. 1c and Supplementary Fig. 1b) , and is essentially indistinguishable from the native mature virus (root mean square deviation: 0.4 Å for 774 Cα atoms matched out of 784; Supplementary  Fig. 1c,d ). The receptor interacts with the virus through helices α 5 and α 7, which-together with α 4-form a bundle lying distal from the domain termini, and therefore from the membrane (Fig. 2a ) 6 . Although this is consistent with the previous inference that the C-terminal end of α 4 is involved in attachment, and the observation that α 5 forms part of the epitope recognized by an antigen-binding fragment, which binds SCARB2 to prevent virus attachment, the binding areas on both the receptor and the virus are quite different from those predicted 3, 7, 8 . It has been noted that this helical bundle undergoes pH-dependent conformational changes, and it has been proposed that these are involved in the pH-dependent triggering of viral uncoating 3, 6 . Interestingly, although our structural analysis was performed at relatively low pH (5.1), the structure of the helical bundle is essentially indistinguishable from that observed for the isolated protein at neutral pH 3, 4, 6 (Fig. 2b,c and Supplementary  Fig. 2a ). This is consistent with our strategy of locking the virus in a pre-uncoating state using a pH-adapted virus and tight-binding pocket factor replacement (see Methods) to prevent the low-pH structural rearrangement in the bound SCARB2, which would initiate viral uncoating. While much of the SCARB2 surface is shielded by nine complex glycans, the EV71-binding site is largely unhindered, although a long well-ordered phosphorylated sugar has been seen to approach this region of the surface 6 (Fig. 2a) . Considering that it is highly exposed in the apo structure, the binding site is surprisingly hydrophobic, suggesting that this region is involved in protein-protein interactions as part of its function in the host. Indeed, it has been proposed that its partner β -glucosidase uses this region as part of its attachment site 6 ( Supplementary Fig. 2b ), and the areas of α 5 and α 7 directly involved in viral interactions make face-to-face contacts with the same region of another SCARB2 molecule in a SCARB2-antigen-binding fragment crystal structure 8 . In addition to hydrophobic interactions, there are limited hydrogen bond and charge interactions, which are described below from the perspective of the virus. Overall, the footprint of the receptor on the virus is ~700 Å 2 , which is similar to that observed for tightly binding antibodies 21 . The SCARB2-binding site on EV71 comprises residues from the VP2 EF and the VP1 GH loops, which form part of the south wall of the canyon and bear antigenic residues. This contrasts with the notion inferred from peptide-scanning assays that receptor binding is mainly contributed by the GH loop and C terminus of VP1 and the GH loop of VP3 (ref. 3 ). The VP2 EF loop is shorter in EV71 than in most enteroviruses (for example, 15 residues shorter than in poliovirus type 1), and residues 134 to 162 from this loop, together with residues 214 to 216 in the VP1 GH loop form a platform on which the receptor sits (Fig. 3a) . The first hypothesis for receptor Viruses using SCARB2, CAR and KREMEN1 as receptors are circled in red, blue and green, respectively. b, EV71-SCARB2 complex viewed down the twofold icosahedral axis, with the left half of the particle shown as a three-dimensional reconstruction coloured by radius from blue, through cyan, green and yellow, to orange from lowest to highest radius, and the right half of the complex shown as ribbons coloured in blue, green, red and orange for VP1, VP2, VP3 and SCARB2, respectively. c,d, Electron potential maps for the bound pocket-binding inhibitor NLD (magenta) and surrounding residues (c), and for residues at the EV71 (green sticks)-SCARB2 (orange sticks) interface (d).
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was that slender receptors would insert into the canyon, thereby allowing the necessarily conserved attachment residues to be concealed from immune surveillance, since the rather blunt antibody would be unable to reach into the canyon 17 . In the intervening years, it has become clear that across picornaviruses, receptor binding can be more varied (summarized in Supplementary Fig. 3 ). Nevertheless in-canyon attachment is common among enteroviruses (exemplified by poliovirus 22 ) and it had been assumed that SCARB2 binding would follow this pattern 7 , so it is surprising that the binding site is essentially a platform that lies outside the canyon, extending to the 'south' (Fig. 3b ). This site is roughly similar to that observed for DAF binding to echovirus 7 (ref. 23 ), and for integrin binding to foot and mouth disease virus 24 , so that current receptor attachment sites for picornaviruses can be grouped into three areas on the virus surface ( Supplementary Fig. 3f ). The SCARB2-binding residues are unremarkable and largely non-conserved, and there is no strong surface charge characterizing the region (Fig. 3c- e and Supplementary  Table 2 ). In summary, there are 14 viral and 19 receptor residues involved in hydrophobic interactions (distance ≤ 4.0 Å), in addition to 4 potential hydrogen bonds and 2 potential charged interactions. Of these, two of the key interactions are with the VP2 main chain (Gly 137 and Pro 147). Of the 14 residues at the viral-receptor interface, 12 are conserved in EV71 genotypes ( Supplementary Fig. 4) . A significant subset of the agents of HFMD use SCARB2 as a receptor (Fig. 1a) ; however, a surprisingly large number of residues in the binding site are not conserved across these viruses (10 out of 14 residues; Supplementary Fig. 4 ). We assume that this variability arises from antigenic variation, which has presumably led to the differentiation of the SCARB2-binding subset of enteroviruses. Indeed, EV71 vaccine does not provide protection against another SCARB2-binding virus, CV-A16. How then do these viruses maintain specificity for SCARB2 in the face of sequence variation? Of the SCARB2-binding residues VP2 Gly 137, Pro 147 and Tyr 148 are conserved. From the antigenic perspective, only the tyrosine presents a signature side-chain recognition signal, but the others have structural properties that can control local protein folding.
All three residues are involved in tight interactions with SCARB2 (Fig. 3c,e ). It appears that the recognition involves a significant proportion of side-chain independent interactions, which may mitigate the constraint imposed on antigenic variation. A snapshot of the generation of variation can be seen in an analysis of the immune response of recovered patients 25 , where the epitopes of the key neutralizing antibodies were mapped by identifying mutations in EV71 that abrogated neutralization. The results are shown in Fig. 4a . It is striking that all except one of the escape mutations are outside the SCARB2 footprint, scattered widely on the capsid, suggesting that neutralizing responses are directed at epitopes that, at most, overlap the receptor-binding site only partially. It appears that, rather akin to the exposed receptor-binding site of foot and mouth disease virus 24 , SCARB2-binding enteroviruses manage to hide their receptor-binding site in full view of the immune response.
In the absence of canyon binding, how might SCARB2 binding and low pH trigger uncoating of EV71? For the canyon-binding receptors, binding to the floor of the canyon could directly induce changes, leading to release of the pocket factor lying directly below, whereas SCARB2 must displace the pocket factor by an allosteric effect. Figure 4b shows the relative position of the SCARB2 attachment site, the pocket-factor-binding site and the conformational changes that occur on transition to the expanded form of the virus and low-pH form for SCARB2 3, 4 . It seems plausible that in the wildtype virus, without additional stabilization of the pocket, structural changes in the SCARB2 helical bundle induced as the pH drops (late endosome/lysosome) would exert mechanical strain on the virus capsid. Specifically, we find that SCARB2 attaches such that the pH-induced conformational change observed previously would act as a lever on the VP1 GH loop through movement of α 7 away from α 5, which is strongly anchored to the VP2 EF loop. This agrees with our previous proposal that the VP1 GH loop, which undergoes conformational changes on particle expansion, acts as the sensor in a sensor-adaptor uncoating mechanism 5, 11, 26 , initiating a cascade of changes, which include the loss or expulsion of the pocket factor and expansion of the particle to facilitate the release of the N terminus of VP1, VP4 and, ultimately, the viral genome. In agreement with this, 
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we note that mutation of one of the VP1 GH loop residues (K215A) increases thermostability, but produces a slow growth phenotype 27 . This mechanism, although attractive, remains speculative pending experimental evidence. Indeed, some experimental results remain hard to explain. For instance, the mutation Q172A in VP1, which is about 30 Å from the binding site, abolished binding to SCARB2 in pull-downs (and a similar result was seen with mutations of neighbouring residues). Also, the VP1 mutations K98E, E145A and L169F enable EV71 to interact with murine SCARB2 (refs. 7, 28 ). Perhaps these residues, distant from the SCARB2-binding site, act through subtle allosteric affects, which agrees with recent data whereby point mutation of one of these residues, VP1 145, affects sensitivity to neutralizing antibodies recognizing a conserved epitope in the EF loop of VP2 (ref. 29 ). In summary, the complex of EV71 with SCARB2 reveals an unexpected mode of attachment, and suggests mechanisms of antigenic camouflage and receptor/pH-mediated uncoating. Knowledge of the specific 'hot spots' of this interaction may help in the design of small molecules, or more likely biologics that block viral entry. For instance, nanobodies, being smaller than antibodies, might be able to target residues that cannot be altered without compromising virus viability. Indeed, an unwitting proof of principle of this has been made by Xu et al. 30 , who grafted parts 
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Methods
Expression and purification of SCARB2. Soluble truncated SCARB2 with His-tag was expressed in HEK 293T cells, as described earlier 6 . Cells were centrifuged at 1,500g for 20 min and the supernatant was dialysed in buffer (1.7 mM NaH 2 PO 4 , 23 mM Na 2 HPO 4 , 250 mM NaCl, pH 8.0) at 4 °C for 48 h. Then, the sample was filtered and loaded onto a 5 ml HisTrap nickel column (GE Healthcare). Buffer (20 mM Tris, 200 mM NaCl, 30 mM imidazole, pH 8.0) was used to wash the nickel column, followed by elution with buffer (20 mM Tris, 200 mM NaCl, 500 mM imidazole, pH 8.0). Then, the eluate was loaded onto a Superdex 75 16/60 gel filtration column (GE Healthcare) for further purification. Buffer (20 mM Tris, 200 mM NaCl, pH 8.0) was used for gel filtration. Purified SCARB2 was concentrated using a 10 kDa ultrafiltration tube (Amicon).
Virus production and purification. Low-pH-enhanced EV71 genotype B2, which has a mutation in VP1 of N104S ( Supplementary Fig. 1c) , was used to infect Vero cells (J.T.K. et al., manuscript submitted). Three days after infection, virus was harvested and 0.5% (v/v) NP-40 was added. The sample was stored at − 80 °C until needed. For purification, the virus sample was subjected to three freeze-thaw cycles to ensure full release of virus from the cells. Then, 8% (w/v) PEG 6000 was added to precipitate the virus. The sample was centrifuged at 3,500g for 1 h at 4 °C, then the pellet was suspended in ~35 ml buffer (100 mM sodium acetate, 200 mM NaCl, 0.5% (v/v) NP-40, pH 5.0) and centrifuged at 3,500g for 30 min at 4 °C to remove cell debris. Virus particles in the supernatant were pelleted through a 2 ml 30% (w/v) sucrose cushion (in 100 mM sodium acetate, 200 mM NaCl, pH 5.0) at 105,000g for 3 h at 4 °C. The pellet was suspended in buffer (100 mM sodium acetate, 200 mM NaCl, 0.5% (v/v) NP-40, pH 5.0) and centrifuged at 12,000g for 30 min at 4 °C to remove insoluble material. The supernatant was then laid on the top of a 15-45% sucrose gradient (in 100 mM sodium acetate, 200 mM NaCl, pH 5.0) and centrifuged at 105,000g for 3 h at 4 °C. Fractions containing EV71 full particles were harvested, and sucrose in the sample was removed using a spin desalting column (Zeba; Pierce). Virus particles in buffer (100 mM sodium acetate, 200 mM NaCl, pH 5.0) were then concentrated using a 100 kDa ultrafiltration tube (Amicon).
Cryo-EM sample preparation. EV71 particles were incubated with the EV71 inhibitor NLD 31,32 at 4 °C for 24 h, with a molar ratio of EV71 particle:NLD of 1:300. Then, 0.5 μ l of SCARB2 (6.5 mg ml −1 , in 20 mM Tris, 200 mM NaCl, pH 8.0) was mixed with 4.5 μ l of EV71 (0.65 mg ml −1 , in 100 mM sodium acetate, 200 mM NaCl, pH 5.0), with a molar ratio of EV71 particle:SCARB2 of 1:100. The pH of the mixture was 5.1. Immediately after this, the mixture was applied to a glow-discharged ultrathin carbon grid (Agar Scientific), blotted by filter paper and vitrified by plunging into liquid ethane using a Vitrobot Mark IV (FEI).
Cryo-EM data collection. Data were collected using a Tecnai Polara microscope (FEI) operating at 300 kV, equipped with a Gatan GIF Quantum energy filter (30 eV energy selecting slit width) and a Gatan K2 Summit direct electron detector. Data were recorded as videos (32 frames, each 0.25 s) in super-resolution mode using SerialEM 33 with a defocus range of 0.5-2.5 μ m. The calibrated magnification was 37,037× , corresponding to a pixel size of 1.35 Å. The dose rate was ~4 e − A −2 s Cryo-EM data processing. Frames of each video were aligned and averaged using MotionCor2 (ref.
34
) and the contrast transfer function parameters were determined with CTFFIND3 (ref. 35 ). Micrographs with astigmatism or significant drift were discarded. Particles were automatically picked using ETHAN 36 , then manually screened in EMAN2 (ref. 37 ). The structure was calculated with Relion 1.3 following the gold-standard refinement procedure 38 . The particles were subjected to reference-free two-dimensional classification. Subsequent template-based threedimensional classification and refinement was performed using initial models generated by filtering the crystal structure of EV71 (Protein Data Bank (PDB): 3VBH 5 ) to 50 Å resolution. The final density map was calculated using 10,443 particles from 757 micrographs, with an overall resolution of 3.4 Å, estimated by Fourier shell correlation 38 ( Supplementary Fig. 1a ).
Model building. The crystal structure of EV71 (PDB: 3VBH
5
) and the structure of SCARB2 (PDB: 4Q4B 6 ) were fitted into the potential map in COOT 39 . The model was further improved using Phenix.real_space_refine 40 . VP1 residues 11-17, VP2 1-9 and VP4 1-11 of EV71 were unclear and not built into the final model. Refinement statistics are given in Supplementary Table 1 .
The residues forming the EV71-SCARB2 interface were identified with PISA 41 . The roadmaps were produced using Rivem 42 . Coordinates 3J6N, 6EIT, 3J8F, 3DPR and 3IYP for virus-receptor complexes of CV-B3-CAR, CV-A24-ICAM-1, PV-1-CD155, HRV-2-V3 (very-low-density lipoprotein module V3) and echovirus 7-DAF, respectively 22, 23, [43] [44] [45] [46] , were used for the preparation of Supplementary Fig. 3 . All figures were prepared with PYMOL 46 and CHIMERA 47 .
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The structure of the EV71-SCARB2 complex is available from the PDB (accession code 6I2K). The map is available from Electron Microscopy Data Bank (accession code EMD-0332). (1)) and distorts the conformation of the VP1 GH loop (2), which in turn triggers release of the VP1 pocket factor and collapse of the pocket (3), viral particle expansion (4) and VP1 N terminus, VP4 and RNA release (5 
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The structure is available from the PDB, accession code 6I2K. The electron density map is available from EMDB, accession code EMD-0332. All studies must disclose on these points even when the disclosure is negative.
Sample size
The final density map was calculated using 10443 particles from 757 micrographs sufficient to provide an overall resolution of 3.4 Å, estimated by Fourier shell correlation Data exclusions Micrographs with astigmatism or significant drift were discarded as is usual practice. Decorated particles were selected by eye.
Replication
Data collected from more than one batch of material and more than one grid. 
